Moderna trial data: COVID-19 vaccine candidate 94.5% effective
Moderna's vaccine candidate has shown 94.5% efficacy in preventing COVID-19 among participants who had not previously been infected with SARS-CoV-2 in the first interim efficacy analysis, the company said.